nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0565	0.215	CbGbCtD
Ezetimibe—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0382	0.145	CbGbCtD
Ezetimibe—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0364	0.139	CbGbCtD
Ezetimibe—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0324	0.124	CbGbCtD
Ezetimibe—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0318	0.121	CbGbCtD
Ezetimibe—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.03	0.114	CbGbCtD
Ezetimibe—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.019	0.0726	CbGbCtD
Ezetimibe—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.018	0.0686	CbGbCtD
Ezetimibe—SOAT1—respiratory system—chronic obstructive pulmonary disease	0.00574	0.102	CbGeAlD
Ezetimibe—ANPEP—respiratory system—chronic obstructive pulmonary disease	0.00549	0.0976	CbGeAlD
Ezetimibe—SOAT1—connective tissue—chronic obstructive pulmonary disease	0.00506	0.0899	CbGeAlD
Ezetimibe—ANPEP—connective tissue—chronic obstructive pulmonary disease	0.00484	0.0859	CbGeAlD
Ezetimibe—SOAT1—bronchus—chronic obstructive pulmonary disease	0.00473	0.084	CbGeAlD
Ezetimibe—SOAT1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00462	0.0822	CbGeAlD
Ezetimibe—ANPEP—bronchus—chronic obstructive pulmonary disease	0.00452	0.0804	CbGeAlD
Ezetimibe—ANPEP—smooth muscle tissue—chronic obstructive pulmonary disease	0.00442	0.0786	CbGeAlD
Ezetimibe—ANPEP—trachea—chronic obstructive pulmonary disease	0.00406	0.0722	CbGeAlD
Ezetimibe—SOAT1—lung—chronic obstructive pulmonary disease	0.00305	0.0542	CbGeAlD
Ezetimibe—ANPEP—lung—chronic obstructive pulmonary disease	0.00292	0.0518	CbGeAlD
Ezetimibe—ABCC3—respiratory system—chronic obstructive pulmonary disease	0.00274	0.0487	CbGeAlD
Ezetimibe—Fluspirilene—SLC6A4—chronic obstructive pulmonary disease	0.00237	0.221	CrCbGaD
Ezetimibe—Fluspirilene—HTR2A—chronic obstructive pulmonary disease	0.00182	0.17	CrCbGaD
Ezetimibe—Flunarizine—CYP1A1—chronic obstructive pulmonary disease	0.00181	0.169	CrCbGaD
Ezetimibe—Flunarizine—CYP1A2—chronic obstructive pulmonary disease	0.00175	0.163	CrCbGaD
Ezetimibe—Pimozide—CYP1A2—chronic obstructive pulmonary disease	0.00161	0.15	CrCbGaD
Ezetimibe—ABCC3—lung—chronic obstructive pulmonary disease	0.00145	0.0258	CbGeAlD
Ezetimibe—Pimozide—HTR2A—chronic obstructive pulmonary disease	0.00136	0.127	CrCbGaD
Ezetimibe—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000881	0.00214	CcSEcCtD
Ezetimibe—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000875	0.00212	CcSEcCtD
Ezetimibe—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000874	0.00212	CcSEcCtD
Ezetimibe—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000874	0.00212	CcSEcCtD
Ezetimibe—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000874	0.00212	CcSEcCtD
Ezetimibe—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000869	0.00211	CcSEcCtD
Ezetimibe—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000868	0.00211	CcSEcCtD
Ezetimibe—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000863	0.00209	CcSEcCtD
Ezetimibe—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000863	0.00209	CcSEcCtD
Ezetimibe—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000856	0.00208	CcSEcCtD
Ezetimibe—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000851	0.00207	CcSEcCtD
Ezetimibe—ABCG2—lung—chronic obstructive pulmonary disease	0.000847	0.0151	CbGeAlD
Ezetimibe—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000845	0.00205	CcSEcCtD
Ezetimibe—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000845	0.00205	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000839	0.00203	CcSEcCtD
Ezetimibe—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000838	0.00203	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000835	0.00203	CcSEcCtD
Ezetimibe—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000835	0.00202	CcSEcCtD
Ezetimibe—Cough—Formoterol—chronic obstructive pulmonary disease	0.000835	0.00202	CcSEcCtD
Ezetimibe—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000828	0.00201	CcSEcCtD
Ezetimibe—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000827	0.00201	CcSEcCtD
Ezetimibe—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000826	0.002	CcSEcCtD
Ezetimibe—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000826	0.002	CcSEcCtD
Ezetimibe—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000825	0.002	CcSEcCtD
Ezetimibe—Cough—Montelukast—chronic obstructive pulmonary disease	0.000818	0.00198	CcSEcCtD
Ezetimibe—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000815	0.00198	CcSEcCtD
Ezetimibe—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000814	0.00198	CcSEcCtD
Ezetimibe—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000814	0.00198	CcSEcCtD
Ezetimibe—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000814	0.00198	CcSEcCtD
Ezetimibe—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000814	0.00198	CcSEcCtD
Ezetimibe—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000814	0.00198	CcSEcCtD
Ezetimibe—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000814	0.00198	CcSEcCtD
Ezetimibe—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000814	0.00198	CcSEcCtD
Ezetimibe—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000811	0.00197	CcSEcCtD
Ezetimibe—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000811	0.00197	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000809	0.00196	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000809	0.00196	CcSEcCtD
Ezetimibe—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000805	0.00195	CcSEcCtD
Ezetimibe—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000805	0.00195	CcSEcCtD
Ezetimibe—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000798	0.00194	CcSEcCtD
Ezetimibe—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000798	0.00193	CcSEcCtD
Ezetimibe—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000798	0.00193	CcSEcCtD
Ezetimibe—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000796	0.00193	CcSEcCtD
Ezetimibe—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000796	0.00193	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000792	0.00192	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000791	0.00192	CcSEcCtD
Ezetimibe—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000788	0.00191	CcSEcCtD
Ezetimibe—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000787	0.014	CbGeAlD
Ezetimibe—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000781	0.00189	CcSEcCtD
Ezetimibe—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000781	0.00189	CcSEcCtD
Ezetimibe—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00078	0.00189	CcSEcCtD
Ezetimibe—Infection—Formoterol—chronic obstructive pulmonary disease	0.000776	0.00188	CcSEcCtD
Ezetimibe—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000776	0.00188	CcSEcCtD
Ezetimibe—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000769	0.00186	CcSEcCtD
Ezetimibe—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000769	0.00186	CcSEcCtD
Ezetimibe—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000769	0.00186	CcSEcCtD
Ezetimibe—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000768	0.00186	CcSEcCtD
Ezetimibe—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000766	0.00186	CcSEcCtD
Ezetimibe—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000766	0.00186	CcSEcCtD
Ezetimibe—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000765	0.00185	CcSEcCtD
Ezetimibe—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000765	0.00185	CcSEcCtD
Ezetimibe—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00076	0.00184	CcSEcCtD
Ezetimibe—Infection—Montelukast—chronic obstructive pulmonary disease	0.00076	0.00184	CcSEcCtD
Ezetimibe—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000759	0.00184	CcSEcCtD
Ezetimibe—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000758	0.00184	CcSEcCtD
Ezetimibe—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000758	0.00184	CcSEcCtD
Ezetimibe—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000756	0.00183	CcSEcCtD
Ezetimibe—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000752	0.00182	CcSEcCtD
Ezetimibe—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00075	0.00182	CcSEcCtD
Ezetimibe—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000749	0.00182	CcSEcCtD
Ezetimibe—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000743	0.0018	CcSEcCtD
Ezetimibe—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000737	0.00179	CcSEcCtD
Ezetimibe—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000732	0.00178	CcSEcCtD
Ezetimibe—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000729	0.00177	CcSEcCtD
Ezetimibe—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000726	0.00176	CcSEcCtD
Ezetimibe—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000723	0.00175	CcSEcCtD
Ezetimibe—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000716	0.00174	CcSEcCtD
Ezetimibe—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000713	0.00173	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000711	0.00173	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000711	0.00173	CcSEcCtD
Ezetimibe—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000706	0.00171	CcSEcCtD
Ezetimibe—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000706	0.00171	CcSEcCtD
Ezetimibe—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000702	0.0017	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000697	0.00169	CcSEcCtD
Ezetimibe—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000696	0.00169	CcSEcCtD
Ezetimibe—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000696	0.00169	CcSEcCtD
Ezetimibe—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000692	0.00168	CcSEcCtD
Ezetimibe—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000687	0.00167	CcSEcCtD
Ezetimibe—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000687	0.00167	CcSEcCtD
Ezetimibe—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000687	0.00167	CcSEcCtD
Ezetimibe—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000684	0.00166	CcSEcCtD
Ezetimibe—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000678	0.00165	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000674	0.00163	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000674	0.00163	CcSEcCtD
Ezetimibe—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000673	0.00163	CcSEcCtD
Ezetimibe—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000673	0.00163	CcSEcCtD
Ezetimibe—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000673	0.00163	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000672	0.00163	CcSEcCtD
Ezetimibe—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000668	0.00162	CcSEcCtD
Ezetimibe—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000668	0.00162	CcSEcCtD
Ezetimibe—Pain—Formoterol—chronic obstructive pulmonary disease	0.000668	0.00162	CcSEcCtD
Ezetimibe—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000668	0.00162	CcSEcCtD
Ezetimibe—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000667	0.00162	CcSEcCtD
Ezetimibe—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000665	0.00161	CcSEcCtD
Ezetimibe—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000662	0.00161	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00066	0.0016	CcSEcCtD
Ezetimibe—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000659	0.0016	CcSEcCtD
Ezetimibe—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000657	0.00159	CcSEcCtD
Ezetimibe—Pain—Montelukast—chronic obstructive pulmonary disease	0.000654	0.00159	CcSEcCtD
Ezetimibe—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000652	0.00158	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00065	0.00158	CcSEcCtD
Ezetimibe—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000649	0.00157	CcSEcCtD
Ezetimibe—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000647	0.00157	CcSEcCtD
Ezetimibe—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000646	0.00157	CcSEcCtD
Ezetimibe—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000643	0.00156	CcSEcCtD
Ezetimibe—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000643	0.00156	CcSEcCtD
Ezetimibe—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000643	0.00156	CcSEcCtD
Ezetimibe—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000641	0.00155	CcSEcCtD
Ezetimibe—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00064	0.00155	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000638	0.00155	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000638	0.00155	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000636	0.00154	CcSEcCtD
Ezetimibe—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000636	0.00154	CcSEcCtD
Ezetimibe—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00063	0.00153	CcSEcCtD
Ezetimibe—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00063	0.00153	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000625	0.00152	CcSEcCtD
Ezetimibe—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00062	0.0015	CcSEcCtD
Ezetimibe—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00062	0.0015	CcSEcCtD
Ezetimibe—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000617	0.0015	CcSEcCtD
Ezetimibe—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000617	0.0015	CcSEcCtD
Ezetimibe—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000617	0.0015	CcSEcCtD
Ezetimibe—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000617	0.0015	CcSEcCtD
Ezetimibe—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000615	0.00149	CcSEcCtD
Ezetimibe—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00061	0.00148	CcSEcCtD
Ezetimibe—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000609	0.00148	CcSEcCtD
Ezetimibe—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000609	0.00148	CcSEcCtD
Ezetimibe—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000607	0.00147	CcSEcCtD
Ezetimibe—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000607	0.00147	CcSEcCtD
Ezetimibe—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000606	0.00147	CcSEcCtD
Ezetimibe—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000604	0.00147	CcSEcCtD
Ezetimibe—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000604	0.00147	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000603	0.00146	CcSEcCtD
Ezetimibe—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000586	0.00142	CcSEcCtD
Ezetimibe—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000583	0.00141	CcSEcCtD
Ezetimibe—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000583	0.00141	CcSEcCtD
Ezetimibe—ABCB1—trachea—chronic obstructive pulmonary disease	0.000581	0.0103	CbGeAlD
Ezetimibe—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000575	0.0014	CcSEcCtD
Ezetimibe—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000575	0.0014	CcSEcCtD
Ezetimibe—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000575	0.00139	CcSEcCtD
Ezetimibe—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000563	0.00137	CcSEcCtD
Ezetimibe—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00056	0.00136	CcSEcCtD
Ezetimibe—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00056	0.00136	CcSEcCtD
Ezetimibe—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000552	0.00134	CcSEcCtD
Ezetimibe—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000552	0.00134	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000551	0.00134	CcSEcCtD
Ezetimibe—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000551	0.00134	CcSEcCtD
Ezetimibe—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000549	0.00133	CcSEcCtD
Ezetimibe—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000543	0.00132	CcSEcCtD
Ezetimibe—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000541	0.00131	CcSEcCtD
Ezetimibe—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000534	0.0013	CcSEcCtD
Ezetimibe—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000534	0.0013	CcSEcCtD
Ezetimibe—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00053	0.00128	CcSEcCtD
Ezetimibe—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000529	0.00128	CcSEcCtD
Ezetimibe—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000523	0.00127	CcSEcCtD
Ezetimibe—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000522	0.00126	CcSEcCtD
Ezetimibe—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000518	0.00126	CcSEcCtD
Ezetimibe—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000516	0.00125	CcSEcCtD
Ezetimibe—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000516	0.00125	CcSEcCtD
Ezetimibe—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000506	0.00123	CcSEcCtD
Ezetimibe—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000504	0.00122	CcSEcCtD
Ezetimibe—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000498	0.00121	CcSEcCtD
Ezetimibe—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000496	0.0012	CcSEcCtD
Ezetimibe—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000496	0.0012	CcSEcCtD
Ezetimibe—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000492	0.00119	CcSEcCtD
Ezetimibe—Rash—Formoterol—chronic obstructive pulmonary disease	0.000492	0.00119	CcSEcCtD
Ezetimibe—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000492	0.00119	CcSEcCtD
Ezetimibe—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000492	0.00119	CcSEcCtD
Ezetimibe—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000489	0.00119	CcSEcCtD
Ezetimibe—Headache—Formoterol—chronic obstructive pulmonary disease	0.000489	0.00119	CcSEcCtD
Ezetimibe—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000487	0.00118	CcSEcCtD
Ezetimibe—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000486	0.00118	CcSEcCtD
Ezetimibe—Rash—Montelukast—chronic obstructive pulmonary disease	0.000482	0.00117	CcSEcCtD
Ezetimibe—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000482	0.00117	CcSEcCtD
Ezetimibe—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000481	0.00117	CcSEcCtD
Ezetimibe—Headache—Montelukast—chronic obstructive pulmonary disease	0.000479	0.00116	CcSEcCtD
Ezetimibe—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000473	0.00115	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000472	0.00115	CcSEcCtD
Ezetimibe—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000469	0.00114	CcSEcCtD
Ezetimibe—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000467	0.00113	CcSEcCtD
Ezetimibe—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000465	0.00113	CcSEcCtD
Ezetimibe—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000464	0.00113	CcSEcCtD
Ezetimibe—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000464	0.00112	CcSEcCtD
Ezetimibe—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000464	0.00112	CcSEcCtD
Ezetimibe—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000462	0.00112	CcSEcCtD
Ezetimibe—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000454	0.0011	CcSEcCtD
Ezetimibe—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000447	0.00108	CcSEcCtD
Ezetimibe—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.00106	CcSEcCtD
Ezetimibe—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000436	0.00106	CcSEcCtD
Ezetimibe—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000425	0.00103	CcSEcCtD
Ezetimibe—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000423	0.00103	CcSEcCtD
Ezetimibe—ABCB1—lung—chronic obstructive pulmonary disease	0.000418	0.00742	CbGeAlD
Ezetimibe—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000401	0.000973	CcSEcCtD
Ezetimibe—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000392	0.000952	CcSEcCtD
Ezetimibe—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000391	0.000947	CcSEcCtD
Ezetimibe—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000382	0.000927	CcSEcCtD
Ezetimibe—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000382	0.000927	CcSEcCtD
Ezetimibe—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00038	0.000921	CcSEcCtD
Ezetimibe—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000379	0.000919	CcSEcCtD
Ezetimibe—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000376	0.000913	CcSEcCtD
Ezetimibe—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000376	0.000913	CcSEcCtD
Ezetimibe—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000362	0.000877	CcSEcCtD
Ezetimibe—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000349	0.000847	CcSEcCtD
Ezetimibe—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000348	0.000845	CcSEcCtD
Ezetimibe—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000348	0.000844	CcSEcCtD
Ezetimibe—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000344	0.000834	CcSEcCtD
Ezetimibe—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000339	0.000823	CcSEcCtD
Ezetimibe—UGT1A3—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000338	0.00131	CbGpPWpGaD
Ezetimibe—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000337	0.00131	CbGpPWpGaD
Ezetimibe—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000336	0.000815	CcSEcCtD
Ezetimibe—UGT2B7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000335	0.0013	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GC—chronic obstructive pulmonary disease	0.000332	0.00128	CbGpPWpGaD
Ezetimibe—UGT2B7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.00033	0.00128	CbGpPWpGaD
Ezetimibe—UGT1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000326	0.00126	CbGpPWpGaD
Ezetimibe—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000325	0.000788	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000322	0.00125	CbGpPWpGaD
Ezetimibe—UGT1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000322	0.00125	CbGpPWpGaD
Ezetimibe—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00032	0.000777	CcSEcCtD
Ezetimibe—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00032	0.000777	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000318	0.00123	CbGpPWpGaD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000318	0.000772	CcSEcCtD
Ezetimibe—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000317	0.000768	CcSEcCtD
Ezetimibe—ANPEP—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	0.000315	0.00122	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000315	0.00122	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000312	0.00121	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000311	0.000755	CcSEcCtD
Ezetimibe—UGT1A1—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.00031	0.0012	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.00031	0.0012	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000309	0.00119	CbGpPWpGaD
Ezetimibe—UGT2B7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000308	0.00119	CbGpPWpGaD
Ezetimibe—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000307	0.000745	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000307	0.00119	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000306	0.00118	CbGpPWpGaD
Ezetimibe—Infection—Prednisone—chronic obstructive pulmonary disease	0.000305	0.00074	CcSEcCtD
Ezetimibe—ANPEP—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	0.000305	0.00118	CbGpPWpGaD
Ezetimibe—UGT2B7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000304	0.00117	CbGpPWpGaD
Ezetimibe—ABCC2—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000303	0.00117	CbGpPWpGaD
Ezetimibe—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000301	0.000731	CcSEcCtD
Ezetimibe—ABCC2—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000299	0.00116	CbGpPWpGaD
Ezetimibe—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000298	0.000724	CcSEcCtD
Ezetimibe—ABCG8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000297	0.00115	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000295	0.00114	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000295	0.00114	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000293	0.00113	CbGpPWpGaD
Ezetimibe—UGT2B7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000292	0.00113	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000291	0.00112	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000291	0.00112	CbGpPWpGaD
Ezetimibe—UGT2B7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000288	0.00111	CbGpPWpGaD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.000287	0.00111	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000286	0.00111	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000285	0.0011	CbGpPWpGaD
Ezetimibe—ABCG8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000282	0.00109	CbGpPWpGaD
Ezetimibe—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00028	0.000679	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00028	0.00108	CbGpPWpGaD
Ezetimibe—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00028	0.000678	CcSEcCtD
Ezetimibe—ABCC2—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000278	0.00108	CbGpPWpGaD
Ezetimibe—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000278	0.000674	CcSEcCtD
Ezetimibe—UGT1A3—Metabolism—APIP—chronic obstructive pulmonary disease	0.000276	0.00107	CbGpPWpGaD
Ezetimibe—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000276	0.000669	CcSEcCtD
Ezetimibe—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	0.000273	0.00106	CbGpPWpGaD
Ezetimibe—UGT1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000272	0.00105	CbGpPWpGaD
Ezetimibe—ABCG5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000272	0.00105	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000271	0.00105	CbGpPWpGaD
Ezetimibe—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00027	0.000656	CcSEcCtD
Ezetimibe—UGT1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000268	0.00104	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000268	0.00104	CbGpPWpGaD
Ezetimibe—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000267	0.000648	CcSEcCtD
Ezetimibe—ABCG2—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000267	0.00103	CbGpPWpGaD
Ezetimibe—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000267	0.000647	CcSEcCtD
Ezetimibe—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000266	0.000646	CcSEcCtD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000265	0.00103	CbGpPWpGaD
Ezetimibe—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000265	0.00102	CbGpPWpGaD
Ezetimibe—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000265	0.000642	CcSEcCtD
Ezetimibe—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000265	0.000642	CcSEcCtD
Ezetimibe—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000263	0.000637	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000258	0.000997	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000257	0.000993	CbGpPWpGaD
Ezetimibe—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000253	0.000614	CcSEcCtD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000253	0.000979	CbGpPWpGaD
Ezetimibe—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000251	0.000609	CcSEcCtD
Ezetimibe—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000251	0.000609	CcSEcCtD
Ezetimibe—UGT1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00025	0.000968	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.00025	0.000966	CbGpPWpGaD
Ezetimibe—UGT1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000247	0.000954	CbGpPWpGaD
Ezetimibe—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000244	0.000592	CcSEcCtD
Ezetimibe—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000243	0.000589	CcSEcCtD
Ezetimibe—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000243	0.000589	CcSEcCtD
Ezetimibe—UGT1A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000237	0.000917	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—APIP—chronic obstructive pulmonary disease	0.000235	0.000908	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000235	0.000908	CbGpPWpGaD
Ezetimibe—UGT1A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000234	0.000905	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000229	0.000887	CbGpPWpGaD
Ezetimibe—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000226	0.000549	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000223	0.000864	CbGpPWpGaD
Ezetimibe—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00022	0.000535	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.00022	0.000852	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000219	0.000848	CbGpPWpGaD
Ezetimibe—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000217	0.000527	CcSEcCtD
Ezetimibe—ABCG5—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000215	0.000832	CbGpPWpGaD
Ezetimibe—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000214	0.000829	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000214	0.000827	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000212	0.00082	CbGpPWpGaD
Ezetimibe—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000211	0.000818	CbGpPWpGaD
Ezetimibe—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.00021	0.00051	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000205	0.000794	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000204	0.00079	CbGpPWpGaD
Ezetimibe—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000203	0.000493	CcSEcCtD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000203	0.000786	CbGpPWpGaD
Ezetimibe—ABCG2—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000203	0.000785	CbGpPWpGaD
Ezetimibe—ANPEP—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	0.000202	0.000783	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000198	0.000764	CbGpPWpGaD
Ezetimibe—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000195	0.000474	CcSEcCtD
Ezetimibe—ABCG8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000195	0.000753	CbGpPWpGaD
Ezetimibe—Rash—Prednisone—chronic obstructive pulmonary disease	0.000194	0.00047	CcSEcCtD
Ezetimibe—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000469	CcSEcCtD
Ezetimibe—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000192	0.000745	CbGpPWpGaD
Ezetimibe—Headache—Prednisone—chronic obstructive pulmonary disease	0.000192	0.000467	CcSEcCtD
Ezetimibe—UGT1A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000191	0.000738	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000189	0.000732	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000187	0.000724	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000183	0.000708	CbGpPWpGaD
Ezetimibe—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000443	CcSEcCtD
Ezetimibe—UGT2B15—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000181	0.000702	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000179	0.000694	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GC—chronic obstructive pulmonary disease	0.000178	0.000688	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000175	0.000676	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—ALB—chronic obstructive pulmonary disease	0.000174	0.000675	CbGpPWpGaD
Ezetimibe—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000174	0.000672	CbGpPWpGaD
Ezetimibe—UGT1A3—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000168	0.000651	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000167	0.000648	CbGpPWpGaD
Ezetimibe—NPC1L1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000167	0.000646	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000165	0.00064	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000164	0.000633	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000162	0.000626	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000159	0.000617	CbGpPWpGaD
Ezetimibe—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000156	0.000602	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000156	0.000602	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000156	0.000602	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000154	0.000597	CbGpPWpGaD
Ezetimibe—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000154	0.000594	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GC—chronic obstructive pulmonary disease	0.000151	0.000585	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GC—chronic obstructive pulmonary disease	0.000151	0.000585	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000151	0.000583	CbGpPWpGaD
Ezetimibe—UGT2B7—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000143	0.000553	CbGpPWpGaD
Ezetimibe—ABCC3—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000143	0.000553	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000141	0.000544	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000141	0.000544	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—ALB—chronic obstructive pulmonary disease	0.000132	0.000512	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—ALB—chronic obstructive pulmonary disease	0.000127	0.000492	CbGpPWpGaD
Ezetimibe—ABCG8—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000126	0.000489	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000126	0.000489	CbGpPWpGaD
Ezetimibe—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.000488	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000126	0.000487	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000125	0.000482	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000124	0.00048	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000123	0.000476	CbGpPWpGaD
Ezetimibe—ABCG5—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000122	0.000471	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000121	0.000467	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	0.000117	0.000452	CbGpPWpGaD
Ezetimibe—UGT1A1—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000116	0.00045	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000116	0.000448	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000116	0.000447	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000115	0.000444	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000114	0.000442	CbGpPWpGaD
Ezetimibe—ABCC2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000113	0.000439	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GC—chronic obstructive pulmonary disease	0.000113	0.000436	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	0.000112	0.000434	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000112	0.000433	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000111	0.000429	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00011	0.000424	CbGpPWpGaD
Ezetimibe—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.00011	0.000424	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00011	0.000424	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000107	0.000415	CbGpPWpGaD
Ezetimibe—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000106	0.000411	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000105	0.000405	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	0.000104	0.000404	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.72e-05	0.000376	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.7e-05	0.000375	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GCLC—chronic obstructive pulmonary disease	9.61e-05	0.000372	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.56e-05	0.00037	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	9.5e-05	0.000367	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	9.22e-05	0.000357	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	9.1e-05	0.000352	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.98e-05	0.000347	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CTGF—chronic obstructive pulmonary disease	8.77e-05	0.000339	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	8.75e-05	0.000339	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	8.72e-05	0.000337	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.34e-05	0.000323	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.32e-05	0.000322	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.26e-05	0.00032	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.26e-05	0.00032	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GCLC—chronic obstructive pulmonary disease	8.17e-05	0.000316	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GCLC—chronic obstructive pulmonary disease	8.17e-05	0.000316	CbGpPWpGaD
Ezetimibe—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	8.14e-05	0.000315	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.08e-05	0.000312	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	7.69e-05	0.000298	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.62e-05	0.000295	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	7.59e-05	0.000294	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CTGF—chronic obstructive pulmonary disease	7.45e-05	0.000288	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CTGF—chronic obstructive pulmonary disease	7.45e-05	0.000288	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—ALB—chronic obstructive pulmonary disease	7.45e-05	0.000288	CbGpPWpGaD
Ezetimibe—ABCC3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	7.24e-05	0.00028	CbGpPWpGaD
Ezetimibe—UGT2B15—Metabolism—NOS3—chronic obstructive pulmonary disease	7.12e-05	0.000276	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	7.07e-05	0.000273	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.97e-05	0.00027	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.87e-05	0.000266	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.87e-05	0.000266	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.74e-05	0.000261	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.72e-05	0.00026	CbGpPWpGaD
Ezetimibe—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	6.7e-05	0.000259	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.64e-05	0.000257	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	6.64e-05	0.000257	CbGpPWpGaD
Ezetimibe—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	6.61e-05	0.000256	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.19e-05	0.00024	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.15e-05	0.000238	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	6.08e-05	0.000235	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	6.06e-05	0.000234	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.87e-05	0.000227	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.8e-05	0.000224	CbGpPWpGaD
Ezetimibe—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.74e-05	0.000222	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.73e-05	0.000222	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.73e-05	0.000222	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.7e-05	0.00022	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.67e-05	0.000219	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.65e-05	0.000219	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.65e-05	0.000219	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	5.64e-05	0.000218	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	5.63e-05	0.000218	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.58e-05	0.000216	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	5.55e-05	0.000215	CbGpPWpGaD
Ezetimibe—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.39e-05	0.000209	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	5.39e-05	0.000209	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.26e-05	0.000204	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.26e-05	0.000204	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.24e-05	0.000203	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.14e-05	0.000199	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.11e-05	0.000198	CbGpPWpGaD
Ezetimibe—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	4.99e-05	0.000193	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.99e-05	0.000193	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.99e-05	0.000193	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.74e-05	0.000183	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.69e-05	0.000181	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.65e-05	0.00018	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.59e-05	0.000178	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.5e-05	0.000174	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.3e-05	0.000166	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.28e-05	0.000165	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.27e-05	0.000165	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.22e-05	0.000163	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.21e-05	0.000163	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.06e-05	0.000157	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.02e-05	0.000155	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—ALB—chronic obstructive pulmonary disease	3.99e-05	0.000154	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.95e-05	0.000153	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.92e-05	0.000152	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.9e-05	0.000151	CbGpPWpGaD
Ezetimibe—UGT1A3—Metabolism—NOS3—chronic obstructive pulmonary disease	3.82e-05	0.000148	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.72e-05	0.000144	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.63e-05	0.00014	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.57e-05	0.000138	CbGpPWpGaD
Ezetimibe—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.54e-05	0.000137	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	3.47e-05	0.000134	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.44e-05	0.000133	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—ALB—chronic obstructive pulmonary disease	3.39e-05	0.000131	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—ALB—chronic obstructive pulmonary disease	3.39e-05	0.000131	CbGpPWpGaD
Ezetimibe—ABCC3—Metabolism—NOS3—chronic obstructive pulmonary disease	3.24e-05	0.000126	CbGpPWpGaD
Ezetimibe—UGT2B7—Metabolism—NOS3—chronic obstructive pulmonary disease	3.24e-05	0.000126	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.23e-05	0.000125	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.08e-05	0.000119	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.05e-05	0.000118	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.78e-05	0.000108	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—ALB—chronic obstructive pulmonary disease	2.76e-05	0.000107	CbGpPWpGaD
Ezetimibe—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.7e-05	0.000104	CbGpPWpGaD
Ezetimibe—UGT1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.64e-05	0.000102	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.56e-05	9.9e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	2.53e-05	9.77e-05	CbGpPWpGaD
Ezetimibe—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.42e-05	9.35e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	2.34e-05	9.05e-05	CbGpPWpGaD
Ezetimibe—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.24e-05	8.65e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.14e-05	8.26e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.11e-05	8.15e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.96e-05	7.59e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.9e-05	7.34e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.88e-05	7.26e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.86e-05	7.2e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.71e-05	6.62e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.58e-05	6.1e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.32e-05	5.09e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.3e-05	5.02e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.26e-05	4.89e-05	CbGpPWpGaD
Ezetimibe—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.21e-05	4.68e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.21e-05	4.68e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.15e-05	4.43e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	7.79e-06	3.01e-05	CbGpPWpGaD
Ezetimibe—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	7.45e-06	2.88e-05	CbGpPWpGaD
